-
Home
-
About PMI
- Welcome to PMI Science
- Our Standards
- Our Scientists
- Our Initiatives
- Interactive tour of the Cube
- Our Network
Latest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
Smoke-free approach
- What is harm reduction?
- Absence of combustion
- Nicotine
- The role of smoke-free products
- Tar
- Tobacco Regulation
Smoke-free approachOffering smoke-free alternatives to adult smokers is a sensible, complementary addition to existing tobacco control strategies.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
Research
- Our Scientific Approach
- Our Findings
- PMI Publications Library
- Literature Reviews
- Independent Studies
- Expert Reports
- Investigator initiated studies (IIS)
- Latest PMI Science Booklet
- Facts and figures on our smoke-free future
ResearchPMI is committed to sharing results as the development and scientific assessment of smoke-free products advance.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
Our Products
- Tobacco Heating System
- Oven Heating System
- MESH Vaping System
- Disposable Vaping System
- Oral Nicotine Pouches
- Nicotine salts product
Our ProductsPMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More -
News & Events
- Scientific Update Magazine
- Open Science Events
- News
- Conferences Calendar
- Media Library
News & EventsRead our most recent articles and catch up on our latest events and conference presentations.Read MoreLatest news smoke-free-products Nicotine pouches join PMI’s smoke-free product portfolio Jan 12, 2023 Read More - Contact Us
-
About PMI
Experimental Models of Environmental Tobacco Smoke Exposure: Structural and Functional Changes in Epithelial Cells of the Respiratory Tract
The health effects of exposure to environmental tobacco smoke (ETS) have been the subject of numerous literature reviews during the past decade. Most of the investigations, which concluded that exposure to ETS may increase the risk of lung cancer, chronic obstructive pulmonary disease (COPD), cardiovascular disease, intrauterine growth retardation, and Sudden Infant Death Syndrome, are based on epidemiological studies (cf. References 1 to 6). In a notice of proposed rulemaking (NPR), the Occupational Safety and Health Administration (OSHA) concluded that ETS “may produce mucous membrane irritation, pulmonary, cardiovascular, reproductive and carcinogenic effects” and that ETS “presents a serious health risk to workers.”
Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters
Quantification and mapping of alkylation in the human genome reveal single nucleotide resolution precursors of mutational signatures
An in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power
Tobacco heating system has less impact on bone metabolism than cigarette smoke
Novel α7 nicotinic acetylcholine receptor modulators as potential antitussive agents
Differentiating the neuropharmacological properties of nicotinic acetylcholine receptor-activating alkaloids
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.